Used in neuroscience research to quantify glial fibrillary acidic protein (GFAP) levels in biological samples, this ELISA kit helps assess astrocyte activation and neuroinflammation. It is widely applied in studies of traumatic brain injury, neurodegenerative diseases such as Alzheimer's and Parkinson's, and multiple sclerosis. Researchers use it to monitor disease progression, evaluate therapeutic interventions, and investigate central nervous system damage in experimental models. The kit enables sensitive and specific detection of GFAP in serum, plasma, cerebrospinal fluid, and tissue homogenates, supporting both clinical and preclinical investigations.